Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TransMedics (TMDX) Non Operating Income (2018 - 2026)

TransMedics has reported Non Operating Income over the past 8 years, most recently at $360000.0 for Q4 2025.

  • For Q4 2025, Non Operating Income rose 121.75% year-over-year to $360000.0; the TTM value through Dec 2025 reached -$1.1 million, up 38.17%, while the annual FY2025 figure was -$1.1 million, 38.17% up from the prior year.
  • Non Operating Income for Q4 2025 was $360000.0 at TransMedics, up from -$269000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $1.4 million in Q3 2023 and troughed at -$1.9 million in Q3 2022.
  • A 5-year average of -$365150.0 and a median of -$312000.0 in 2024 define the central range for Non Operating Income.
  • Biggest five-year swings in Non Operating Income: soared 1515.38% in 2023 and later crashed 2639.29% in 2025.
  • Year by year, Non Operating Income stood at -$1.3 million in 2021, then skyrocketed by 105.9% to $78000.0 in 2022, then soared by 1515.38% to $1.3 million in 2023, then tumbled by 231.35% to -$1.7 million in 2024, then skyrocketed by 121.75% to $360000.0 in 2025.
  • Business Quant data shows Non Operating Income for TMDX at $360000.0 in Q4 2025, -$269000.0 in Q3 2025, and -$385000.0 in Q2 2025.